US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G

The hybrid closed-loop automated insulin delivery system, the first closed-loop system approved anywhere in the world, automatically monitors glucose and provides appropriate basal insulin doses in people with type 1 diabetes.

A major milestone has been met in diabetes. US FDA announced Sept. 28 the approval of Medtronic PLC's MiniMed 670G hybrid closed-looped automated insulin delivery system.

It's the first hybrid closed-loop insulin delivery system approved anywhere in the world, according to the company, making it the first so-called "artificial pancreas," says FDA. (Also see "From...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Approvals

More from Policy & Regulation